|
KLRA Kailera Therapeutics Inc 2096997 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-78,865,000.00 |
| Balance Sheet |
|
Current Assets
|
$530,315,000.00 |
|
Assets
|
$624,756,000.00 |
|
Current Liabilities
|
$54,836,000.00 |
|
Liabilities
|
$64,480,000.00 |
|
Equity
|
$-432,088,000.00 |
|
Shares Out
|
29953.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-68,310,000.00 |
|
Investing Cash Flow
|
$22,849,000.00 |
| Market Analysis |
Market Cap
|
$510,698.65 |
|
Price
|
$17.08 |
|
PB
|
1.35 |
|
EPS
|
-3650.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KLRA documents filed with the SEC.
KLRA Filings
Clear
